Company Filing History:
Years Active: 2023
Title: Innovations by Giorgio Ottaviani
Introduction
Giorgio Ottaviani is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of modified IL-2 polypeptides. His work focuses on innovative treatments for diseases, including cancer.
Latest Patents
Giorgio Ottaviani holds a patent for "Modified IL-2 polypeptides and uses thereof." This patent relates to modified IL-2 polypeptides, compositions comprising these polypeptides, methods of making them, and their applications in treating diseases. Notably, the patent emphasizes the treatment of cancer using these modified IL-2 polypeptides. The disclosed IL-2 polypeptides exhibit preferential binding characteristics to the IL-2 receptor βγ complex (IL-2Rβ) over the IL-2 receptor αβγ complex (IL-2Rα). Additionally, the molecular weight distribution of the modified IL-2 polypeptides is monodispersed.
Career Highlights
Giorgio Ottaviani is associated with Bright Peak Therapeutics AG, where he continues to advance his research and innovations. His work has the potential to impact the treatment landscape for various diseases, particularly in oncology.
Collaborations
Giorgio collaborates with esteemed colleagues, including Vijaya Raghavan Pattabiraman and Roberto Iacone. Their combined expertise contributes to the advancement of their research initiatives.
Conclusion
Giorgio Ottaviani's innovative work in the field of modified IL-2 polypeptides showcases his commitment to advancing medical treatments. His contributions are paving the way for new therapeutic options in cancer treatment.